EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in vaccine research and development.
EmVenio Research was represented by many members of their team including President, Thad Wolfram, who was invited to speak at the conference during two round table discussions and a presentation with Parexel. Wolfram spoke about EmVenio’s community research sites and the importance of community engagement for optimal clinical trial enrollment and success.
During his presentation, Wolfram highlighted EmVenio’s unique approach to localized clinical trials, which focuses on community involvement and bringing clinical trial access to diverse and underserved communities.
In addition to Thad’s round table discussions and presentation, EmVenio Research also had a booth at the conference where attendees could learn more about the company’s capabilities and speak with the business development, operations, and marketing members. The team met with a variety of sponsors, CROs, site organizations, and patient recruitment companies who shared an interest in exploring how we can collectively benefit vaccine research and patients.
The World Vaccine Congress provided EmVenio Research with an opportunity to network with other industry leaders and showcase their approach to vaccine trials. The conference also provided a platform for EmVenio to collaborate with other organizations on future vaccine trial projects.
“We are thrilled to have had the opportunity to participate in the World Vaccine Congress,” said Thad Wolfram. “It was an excellent platform for us to bring awareness to our approach to clinical research and engage with other leaders in the field. We are excited about the potential collaborations and partnerships that will come out of this conference.”
Overall, EmVenio Research’s attendance at the World Vaccine Congress was a great success. The conference provided an opportunity to showcase tactics to diversify clinical trials, network with other industry leaders, and form new partnerships that could help accelerate the development of life-saving vaccines.
For upcoming events please visit www.emvenio.com/events